US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
GB8609537D0
(en)
*
|
1986-04-18 |
1986-05-21 |
Ici Plc |
Polyesters
|
DE3720806C2
(de)
*
|
1986-07-03 |
1997-08-21 |
Clariant Finance Bvi Ltd |
Verwendung eines Stabilisators in Peroxydbleichverfahren
|
US4758435A
(en)
*
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
DE3641692A1
(de)
*
|
1986-12-06 |
1988-06-09 |
Boehringer Ingelheim Kg |
Katalysatorfreie resorbierbare homopolymere und copolymere
|
DE3710175A1
(de)
*
|
1987-02-12 |
1988-08-25 |
Hoechst Ag |
Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
|
US5180765A
(en)
*
|
1988-08-08 |
1993-01-19 |
Biopak Technology, Ltd. |
Biodegradable packaging thermoplastics from lactides
|
US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
US5424346A
(en)
*
|
1988-08-08 |
1995-06-13 |
Ecopol, Llc |
Biodegradable replacement of crystal polystyrene
|
AU634723B2
(en)
*
|
1988-08-08 |
1993-03-04 |
Biopak Technology, Ltd. |
Degradable thermoplastic from lactides
|
BR8907604A
(pt)
*
|
1988-08-08 |
1991-07-30 |
Battelle Memorial Institute |
Composicao ambientalmente biodegradavel,processo para produzir a mesma e processo para tornar uma composicao de polimero termoplastico ambientalmente biodegradavel
|
US5250584A
(en)
*
|
1988-08-31 |
1993-10-05 |
G-C Dental Industrial Corp. |
Periodontium-regenerative materials
|
JP2714454B2
(ja)
*
|
1988-11-07 |
1998-02-16 |
三井東圧化学株式会社 |
生体吸収性ポリエステルの製造方法
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
US5126147A
(en)
*
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
DE4005415C2
(de)
*
|
1990-02-21 |
1996-04-11 |
Boehringer Ingelheim Kg |
Verfahren zum Herstellen von Polyestern auf der Basis von Hydroxycarbonsäuren
|
US5288496A
(en)
*
|
1990-05-15 |
1994-02-22 |
Stolle Research & Development Corporation |
Growth promoters for animals
|
US5733566A
(en)
*
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US6353030B1
(en)
*
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
MY108621A
(en)
*
|
1990-08-01 |
1996-10-31 |
Novartis Ag |
Polylactide preparation and purification
|
ZA918168B
(en)
|
1990-10-16 |
1993-04-14 |
Takeda Chemical Industries Ltd |
Prolonged release preparation and polymers thereof.
|
IT1249045B
(it)
*
|
1991-02-21 |
1995-02-11 |
Himont Inc |
Processo per la sintesi allo stato solido di polimeri dell'acido lattico e prodotti cosi ottenuti
|
US5247059A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for the manufacture of a purified lactide from esters of lactic acid
|
US5142023A
(en)
*
|
1992-01-24 |
1992-08-25 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5258488A
(en)
*
|
1992-01-24 |
1993-11-02 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6005067A
(en)
*
|
1992-01-24 |
1999-12-21 |
Cargill Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247058A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6326458B1
(en)
|
1992-01-24 |
2001-12-04 |
Cargill, Inc. |
Continuous process for the manufacture of lactide and lactide polymers
|
US5294469A
(en)
*
|
1992-06-17 |
1994-03-15 |
Mitsui Toatsu Chemicals, Incorporated |
Industrial woven fabric and composite sheet comprising same
|
US5758053A
(en)
*
|
1992-07-22 |
1998-05-26 |
Hitachi, Ltd. |
Fault handling and recovery for system having plural processors
|
DE69322155T2
(de)
*
|
1992-10-02 |
1999-08-19 |
Cargill Inc |
Papier mit einer beschichtung aus schmelzstabilem polymer und dessen verfahren zur herstellung
|
PT615555E
(pt)
*
|
1992-10-02 |
2001-09-28 |
Cargill Inc |
Tecido de polimero de lactido estavel no estado de massa fundida e processo para a sua preparacao
|
US6005068A
(en)
*
|
1992-10-02 |
1999-12-21 |
Cargill Incorporated |
Melt-stable amorphous lactide polymer film and process for manufacture thereof
|
US5338822A
(en)
*
|
1992-10-02 |
1994-08-16 |
Cargill, Incorporated |
Melt-stable lactide polymer composition and process for manufacture thereof
|
US5686092A
(en)
*
|
1992-11-24 |
1997-11-11 |
Alkermes Controlled Therapeutics Inc. Ii |
Growth promoters for animals
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
KR100354270B1
(ko)
*
|
1993-11-19 |
2003-02-11 |
알커메스 컨트롤드 테라포이틱스 인코퍼레이티드 Ii |
마이크로캡슐화된3-피페리디닐-치환된1,2-벤즈이속사졸및1,2-벤즈이소티아졸
|
DE69611513T2
(de)
*
|
1995-08-29 |
2001-07-19 |
Kyowa Hakko Kogyo Kk |
Verfahren zur herstellung von polyhydroxycarbonsäure
|
SE505146C2
(sv)
*
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
AU1732897A
(en)
*
|
1996-02-23 |
1997-09-10 |
Kyowa Hakko Kogyo Co. Ltd. |
Process for the preparation of polyhydroxycarboxylic acid
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US6126919A
(en)
*
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6113947A
(en)
*
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6733767B2
(en)
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
US6217844B1
(en)
|
1998-04-27 |
2001-04-17 |
Praecis Pharmaceuticals, Inc. |
Methods for detecting lesions in dense breast tissue using LHRH antagonists
|
EP1242500B1
(de)
|
1999-12-10 |
2005-04-20 |
Equipolymers GmbH |
Katalysatorsysteme für polykondensationsreaktionen
|
US6960626B2
(en)
*
|
2000-01-21 |
2005-11-01 |
Cyclics Corporation |
Intimate physical mixtures containing macrocyclic polyester oligomer and filler
|
EP1310517B2
(de)
*
|
2000-08-07 |
2010-11-17 |
Wako Pure Chemical Industries, Ltd. |
Milchsäurepolymer und verfahren zu dessen herstellung
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
ES2311542T3
(es)
*
|
2000-08-16 |
2009-02-16 |
Tyco Healthcare Group Lp |
Resina polimerica absorbible de gran consistencia.
|
US7767781B2
(en)
|
2000-09-01 |
2010-08-03 |
Cyclics Corporation |
Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
|
US7750109B2
(en)
|
2000-09-01 |
2010-07-06 |
Cyclics Corporation |
Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
|
AU2002324447B2
(en)
*
|
2001-06-22 |
2006-06-29 |
Durect Corporation |
Zero-order prolonged release coaxial implants
|
WO2003002551A1
(en)
|
2001-06-27 |
2003-01-09 |
Cyclics Corporation |
Isolation, formulation, and shaping of macrocyclic oligoesters
|
TWI225416B
(en)
|
2001-06-29 |
2004-12-21 |
Takeda Chemical Industries Ltd |
Sustained-release composition and process for producing the same
|
TWI332407B
(en)
|
2001-06-29 |
2010-11-01 |
Takeda Chemical Industries Ltd |
Controlled release composition and method of producting the same
|
JP2003192773A
(ja)
*
|
2001-12-26 |
2003-07-09 |
Mitsui Chemicals Inc |
生体吸収性ポリヒドロキシカルボン酸及びその製造法
|
US6849600B2
(en)
*
|
2002-03-25 |
2005-02-01 |
The Regents Of The University Of California, Berkeley |
Corticotropin-releasing hormone analogs
|
ATE369388T1
(de)
*
|
2002-09-24 |
2007-08-15 |
Asahi Kasei Chemicals Corp |
Glycolsaüre copolymer und verfahren zu dessen herstellung
|
EP1440992A1
(de)
*
|
2003-01-21 |
2004-07-28 |
Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) |
Katalysatorzusammensetzung für die (Co)polymerisation von Lactid und Glycolid
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
CA2533314C
(en)
|
2003-07-18 |
2013-07-09 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
WO2005105908A1
(ja)
*
|
2004-04-28 |
2005-11-10 |
Keio University |
主鎖にエステル結合を有するポリマーの解重合方法及び解重合生成物から主鎖にエステル結合を有するポリマーを製造する方法
|
ES2357243T3
(es)
*
|
2004-05-21 |
2011-04-20 |
Micro Therapeutics, Inc. |
Espirales metálicas entrelazadas con polímeros o fibras biológicos o biodegradables o sintéticos para la embolización de una cavidad corporal.
|
US20070254314A1
(en)
*
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
WO2006032291A1
(de)
*
|
2004-09-22 |
2006-03-30 |
Dendron Gmbh |
Vorrichtung zur implantation von mikrowendeln
|
DE102005019782A1
(de)
*
|
2005-04-28 |
2006-11-09 |
Dendron Gmbh |
Vorrichtung zur Implantation von Okklusionswendeln mit innenliegendem Sicherungsmittel
|
US7342048B2
(en)
*
|
2005-04-28 |
2008-03-11 |
Nipro Corporation |
Bioabsorbable pharmaceutical formulation
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
US8882747B2
(en)
*
|
2005-11-09 |
2014-11-11 |
The Invention Science Fund I, Llc |
Substance delivery system
|
WO2007067964A2
(en)
*
|
2005-12-08 |
2007-06-14 |
Nastech Pharmaceutical Company Inc. |
Mucosal delivery of stabilized formulations of exendin
|
ES2761949T3
(es)
|
2006-11-01 |
2020-05-21 |
Ventana Med Syst Inc |
Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso
|
WO2008075762A1
(en)
|
2006-12-18 |
2008-06-26 |
Takeda Pharmaceutical Company Limited |
Sustained-release composition and method for producing the same
|
AU2008226694B8
(en)
|
2007-03-13 |
2013-06-20 |
Covidien Lp |
An implant including a coil and a stretch-resistant member
|
KR20110038139A
(ko)
|
2008-07-17 |
2011-04-13 |
메리얼 리미티드 |
폴리오르소에스테르 및 이의 제형의 안정성 강화 방법
|
JP5718233B2
(ja)
|
2008-10-20 |
2015-05-13 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
甲状腺刺激ホルモン受容体(tshr)の低分子量アゴニスト
|
US8653086B2
(en)
|
2008-10-21 |
2014-02-18 |
Oregon Health & Science University |
Naphthamides as anticancer agents
|
CN101445595B
(zh)
*
|
2008-12-26 |
2011-01-19 |
上海新上化高分子材料有限公司 |
聚乙丙交酯及其制备方法和应用
|
WO2011094426A1
(en)
|
2010-01-29 |
2011-08-04 |
The United State Of America, As Represented By The Secretary, Department Of Health & Human Services |
Caspase inhibitors
|
WO2011127388A2
(en)
|
2010-04-08 |
2011-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inverse agonists and neutral antagonists for the tsh receptor
|
WO2012125486A1
(en)
|
2011-03-11 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination chemotherapy for treating cancer
|
WO2012125787A1
(en)
|
2011-03-17 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY CBFβ AND RUNX1 PROTEINS
|
CN102295765B
(zh)
*
|
2011-06-30 |
2012-11-28 |
南京大学 |
生物质肌酐催化共缩聚法合成聚乳酸-乙醇酸
|
CN102329269B
(zh)
*
|
2011-06-30 |
2013-07-17 |
南京大学 |
仿生氯化肌酐胍催化缩聚法合成高分子量聚乳酸
|
WO2013039792A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunogens based on an hiv-1 gp120 v1v2 epitope
|
US20140234360A1
(en)
|
2011-09-30 |
2014-08-21 |
The United States of America, as represented by the Secretary, Dept.of Health and Human Services |
Influenza vaccine
|
WO2013106847A1
(en)
|
2012-01-13 |
2013-07-18 |
Oregon Health & Science University |
Compounds, compositions and associated methods comprising 3-aryl quinolines
|
JP6275703B2
(ja)
|
2012-06-08 |
2018-02-07 |
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
Fbxo3阻害剤
|
EP2919779B1
(de)
|
2012-11-13 |
2021-01-06 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Cannabinoid rezeptor mediatoren
|
US9775895B2
(en)
|
2012-12-12 |
2017-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HIV therapeutics and methods of making and using same
|
CA2912064A1
(en)
|
2013-05-16 |
2014-11-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for inhibiting drug-resistant strains of hiv-1 integrase
|
EP3046561B1
(de)
|
2013-09-20 |
2023-02-22 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Verbindungen zur behandlung von prostatakrebs
|
WO2015106003A1
(en)
|
2014-01-08 |
2015-07-16 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Ras pathways as markers of protection against hiv and methods to improve vaccine efficacy
|
CA2948349C
(en)
|
2014-05-09 |
2023-03-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Pyrazole derivatives and their use as cannabinoid receptor mediators
|
US10266549B2
(en)
|
2014-08-25 |
2019-04-23 |
Salk Institute For Biological Studies |
ULK1 inhibitors and methods using same
|
US10400015B2
(en)
|
2014-09-04 |
2019-09-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant HIV-1 envelope proteins and their use
|
WO2016064716A1
(en)
|
2014-10-20 |
2016-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination therapy of tshr antagonist and igfr inhibitor
|
US10420834B2
(en)
|
2014-12-24 |
2019-09-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus F proteins and their use
|
WO2016112036A1
(en)
|
2015-01-05 |
2016-07-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Myc g-quadruplex stabilizing small molecules and their use
|
CN107848940A
(zh)
|
2015-02-20 |
2018-03-27 |
俄勒冈健康科学大学 |
Sobeirome衍生物
|
EP3303325A1
(de)
|
2015-06-04 |
2018-04-11 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Cannabinoid-rezeptorvermittelnde verbindungen
|
WO2017044803A1
(en)
|
2015-09-09 |
2017-03-16 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Service |
Expression vector delivery system and use thereof for inducing an immune response
|
CN108699043A
(zh)
|
2016-03-04 |
2018-10-23 |
美国政府(由卫生和人类服务部的部长所代表) |
大麻素受体介导化合物
|
PT3457851T
(pt)
|
2016-05-18 |
2021-09-28 |
Univ Oregon Health & Science |
Derivados de sobetiroma
|
WO2017218963A1
(en)
|
2016-06-16 |
2017-12-21 |
Acies Bio D.O.O. |
Compositions and methods useful for treating diseases characterized by insufficient pantothenate kinase activity
|
EP3554538A2
(de)
|
2016-12-16 |
2019-10-23 |
Institute for Research in Biomedicine |
Neuartige rekombinante rsv-f-präfusionsproteine und verwendungen davon
|
SG11202001688WA
(en)
|
2017-08-31 |
2020-03-30 |
Evonik Corp |
Improved resorbable polymer purification process
|
WO2019118803A1
(en)
|
2017-12-14 |
2019-06-20 |
The United States Of America, As Represented By The Secretary,Department Of Health And Human Services |
Chemical entities for lytic activation of kshv and therapeutic targeting of viral enzymes/proteins
|
WO2019191502A1
(en)
|
2018-03-29 |
2019-10-03 |
Elex Biotech, Inc. |
Compounds for treatment of cardiac arrhythmias and heart failure
|
JP2022502378A
(ja)
|
2018-09-25 |
2022-01-11 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
2’−ハロゲン化−4’−チオ−2’−デオキシ−5−アザシチジンアナログおよびその使用
|
WO2020123861A1
(en)
|
2018-12-12 |
2020-06-18 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
EP3931180A1
(de)
|
2019-03-01 |
2022-01-05 |
Autobahn Therapeutics, Inc. |
Neuartige thyromimetika
|
WO2020185695A1
(en)
|
2019-03-11 |
2020-09-17 |
Oregon State University |
Analogues and derivatives of cephalotaxine and methods for making and using the compounds
|
CA3222837A1
(en)
|
2021-06-09 |
2022-12-15 |
John S. Schneekloth |
Compounds that bind non-canonical g-quadruplex structures and methods of making and using the same
|
WO2023059867A1
(en)
|
2021-10-08 |
2023-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for treating or preventing alzheimer's disease
|
WO2023146771A1
(en)
|
2022-01-25 |
2023-08-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gingerenone a prodrugs as senotherapeutics and methods of use
|
WO2023177568A1
(en)
|
2022-03-14 |
2023-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor modulating compounds
|